av/impedimed-ltd--big.svg

COM:IMPEDIMED

ImpediMed

  • Stock

Last Close

0.06

25/11 05:10

Market Cap

137.57M

Beta: -

Volume Today

1.12M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jun '14
Jun '15
Jun '16
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
Jun '22
Jun '23
Jun '24
average inventory
1.23M
-
1.39M
12.51%
1.51M
8.88%
1.42M
5.74%
1.64M
15.23%
1.47M
10.50%
992.50K
32.30%
618K
37.73%
649K
5.02%
868K
33.74%
784.50K
9.62%
average payables
326.50K
-
740.50K
126.80%
1.48M
99.80%
1.99M
34.17%
2.33M
17.33%
2.30M
1.20%
2.00M
13.10%
1.60M
19.75%
1.97M
22.59%
2.00M
1.50%
1.23M
38.62%
average receivables
447K
-
539K
20.58%
2.07M
284.04%
3.66M
76.59%
4.05M
10.93%
3.90M
3.90%
3.61M
7.39%
3.72M
3.01%
3.56M
4.25%
3.63M
1.94%
3.79M
4.55%
book value per share
0.06
-
0.12
92.86%
0.25
105.25%
0.15
41.12%
0.09
39.15%
0.04
56.41%
0.05
15.75%
0.02
53.84%
0.03
43.27%
0.04
40.19%
0.02
52.72%
capex per share
-0.00
-
-0.00
209.03%
-0.00
30.74%
-0.00
183.52%
-0.00
233.55%
-0.01
81.99%
-0.00
35.11%
-0.00
43.72%
-0.00
52.17%
-0.00
36.05%
0.00
136.30%
capex to depreciation
-0.18
-
-0.73
312.50%
-0.59
18.32%
-1.42
139.64%
-2.74
92.76%
-1.89
-
1.38
-
capex to operating cash flow
0.00
-
0.01
160.84%
0.00
60.38%
0.01
191.27%
0.05
265.80%
0.11
119.21%
0.11
0.96%
0.19
64.81%
0.31
64.70%
0.33
9.69%
-0.17
152.13%
capex to revenue
-0.01
-
-0.03
199.84%
-0.02
30.93%
-0.06
233.55%
-0.25
303.43%
-0.54
114.27%
-0.38
30.07%
-0.29
22.50%
-0.50
69.13%
-0.54
7.99%
0.30
156.01%
cash per share
0.05
-
0.12
125.76%
0.25
111.73%
0.14
43.04%
0.08
43.24%
0.03
64.06%
0.03
15.89%
0.02
50.45%
0.02
48.20%
0.03
31.91%
0.01
61.93%
days of inventory on hand
302.47
-
451.56
49.29%
317.73
29.64%
359.12
13.03%
414.17
15.33%
326.81
21.09%
187.94
42.49%
84.76
54.90%
197.77
133.34%
191.24
3.30%
11.40
94.04%
days payables outstanding
93.52
-
311.79
233.39%
421.49
35.18%
525.07
24.57%
575.40
9.59%
608.14
5.69%
416.12
31.58%
295.28
29.04%
563.41
90.81%
319.91
43.22%
16.47
94.85%
days sales outstanding
46.13
-
47.70
3.40%
221.04
363.43%
240.80
8.94%
327.64
36.06%
310.67
5.18%
239.10
23.04%
161.90
32.29%
118.73
26.66%
124.70
5.02%
113.30
9.14%
debt to assets
0.03
-
0.01
47.40%
0.00
79.10%
0.02
626.89%
0.02
15.56%
debt to equity
0.03
-
0.02
41.64%
0.00
82.07%
0.02
613.67%
0.03
18.03%
dividend yield
0.00
-
earnings yield
-0.21
-
-0.06
70.92%
-0.08
34.79%
-0.09
13.40%
-0.18
87.22%
-0.53
198.28%
-0.58
10.34%
-0.16
71.69%
-0.19
18.31%
-0.08
58.87%
-0.14
72.74%
enterprise value
26.70M
-
207.99M
678.97%
231.10M
11.12%
238.37M
3.15%
123.04M
48.38%
34.38M
72.06%
18.11M
47.32%
107.04M
491.09%
61.86M
42.21%
212.85M
244.10%
120.05M
43.60%
enterprise value over ebitda
-3.41
-
-13.87
306.18%
-8.89
35.90%
-7.82
12.08%
-4.08
47.84%
-1.31
67.98%
-0.75
42.50%
-5.01
567.09%
-3.30
34.19%
-10.39
215.14%
-5.53
46.79%
ev to operating cash flow
-3.93
-
-19.33
392.57%
-10.31
46.69%
-9.32
9.54%
-5.25
43.75%
-1.75
66.54%
-0.94
46.31%
-8.07
756.81%
-3.62
55.21%
-11.79
226.10%
-6.75
42.77%
ev to sales
7.58
-
42.94
466.22%
39.91
7.06%
41.34
3.59%
25.65
37.96%
8.39
67.30%
3.18
62.09%
12.81
302.93%
5.89
54.00%
18.92
221.04%
11.63
38.51%
free cash flow per share
-0.03
-
-0.04
19.37%
-0.07
73.54%
-0.07
1.76%
-0.06
5.43%
-0.05
12.11%
-0.04
34.55%
-0.01
63.61%
-0.01
1.74%
-0.02
26.84%
-0.01
38.73%
free cash flow yield
-0.18
-
-0.05
75.15%
-0.07
58.85%
-0.09
22.96%
-0.16
80.76%
-0.48
198.62%
-0.58
21.40%
-0.12
78.51%
-0.22
75.12%
-0.09
57.02%
-0.15
55.34%
graham net net
0.05
-
0.11
124.30%
0.24
118.58%
0.13
43.70%
0.08
44.20%
0.02
74.20%
0.03
48.87%
0.01
59.81%
0.02
85.25%
0.03
33.96%
0.01
63.64%
graham number
0.23
-
0.38
64.14%
0.67
73.85%
0.49
26.96%
0.38
22.80%
0.23
38.14%
0.19
17.02%
0.09
52.95%
0.09
0.77%
0.12
30.44%
0.07
43.24%
income quality
0.86
-
0.73
15.19%
0.86
18.72%
0.93
7.44%
0.86
6.90%
0.86
-
0.90
-
intangibles to total assets
0.13
-
0.06
51.66%
0.03
56.94%
0.04
37.07%
0.08
123.80%
0.24
183.73%
0.20
17.13%
0.22
10.45%
0.19
11.12%
0.21
10.99%
0.34
58.71%
interest coverage
9.19
-
-1.20K
-
-257.78
-
interest debt per share
-0.01
-
0.00
119.78%
0.00
73.06%
0.00
71.60%
0.00
804.69%
0.00
39.65%
inventory turnover
1.21
-
0.81
33.02%
1.15
42.12%
1.02
11.52%
0.88
13.29%
1.12
26.73%
1.94
73.89%
4.31
121.74%
1.85
57.14%
1.91
3.42%
32.01
1,577.07%
invested capital
0.03
-
0.02
41.64%
0.00
82.07%
0.02
613.67%
42.27M
177,861,763,894.47%
market cap
37.51M
-
240.57M
541.31%
313.36M
30.26%
293.26M
6.41%
154.39M
47.36%
45.71M
70.40%
36.90M
19.26%
126.24M
242.12%
102.42M
18.87%
257.11M
151.05%
143.54M
44.17%
net current asset value
11.31M
-
32.04M
183.17%
82.33M
156.99%
55.71M
32.34%
32.03M
42.50%
10.18M
68.23%
19.75M
94.04%
16.96M
14.12%
39.01M
130.00%
44.08M
13.01%
23.21M
47.33%
net debt to ebitda
1.38
-
2.17
57.14%
3.16
45.64%
1.80
43.12%
1.04
42.29%
0.43
58.57%
0.78
81.05%
0.90
15.35%
2.16
140.48%
2.16
0.06%
1.08
49.93%
net income per share
-0.04
-
-0.05
39.70%
-0.08
47.26%
-0.07
9.40%
-0.07
2.05%
-0.06
12.20%
-0.04
40.51%
-0.02
52.05%
-0.01
31.27%
-0.01
21.37%
-0.01
31.86%
operating cash flow per share
-0.03
-
-0.04
18.47%
-0.07
74.82%
-0.07
2.66%
-0.06
8.82%
-0.05
16.98%
-0.03
34.48%
-0.01
65.85%
-0.01
7.61%
-0.01
24.03%
-0.01
30.37%
payables turnover
3.90
-
1.17
70.01%
0.87
26.03%
0.70
19.73%
0.63
8.75%
0.60
5.38%
0.88
46.15%
1.24
40.92%
0.65
47.59%
1.14
76.12%
22.17
1,842.84%
receivables turnover
7.91
-
7.65
3.28%
1.65
78.42%
1.52
8.21%
1.11
26.50%
1.17
5.46%
1.53
29.93%
2.25
47.69%
3.07
36.35%
2.93
4.78%
3.22
10.06%
research and ddevelopement to revenue
0.11
-
0.21
87.61%
0.70
226.59%
0.93
32.62%
0.62
32.89%
0.72
16.23%
0.58
19.51%
0.17
70.00%
0.07
62.66%
0.05
18.31%
0.02
59.71%
return on tangible assets
-0.61
-
-0.42
31.77%
-0.29
29.23%
-0.45
50.95%
-0.71
59.53%
-1.39
96.37%
-0.81
42.25%
-0.77
3.90%
-0.42
45.75%
-0.38
9.43%
-0.64
68.09%
revenue per share
0.02
-
0.02
3.06%
0.02
0.27%
0.01
15.00%
0.01
17.32%
0.01
15.06%
0.01
7.22%
0.01
27.38%
0.01
10.03%
0.01
25.99%
0.01
35.19%
roe
-0.59
-
-0.42
27.57%
-0.30
28.26%
-0.47
53.88%
-0.75
60.96%
-1.52
101.40%
-0.78
48.61%
-0.81
3.87%
-0.39
52.02%
-0.34
13.43%
-0.49
44.10%
roic
-0.59
-
-0.43
26.54%
-0.31
29.23%
-0.52
71.60%
-0.85
62.73%
-1.71
101.19%
-0.88
48.68%
-0.87
0.75%
-0.42
51.91%
-0.36
14.05%
-0.55
51.36%
sales general and administrative to revenue
1.86
-
2.56
37.59%
3.27
27.75%
3.85
17.69%
4.77
23.94%
4.87
2.16%
3.30
32.20%
2.56
22.38%
1.86
27.34%
1.73
6.95%
2.14
23.48%
shareholders equity per share
0.06
-
0.12
92.86%
0.25
105.25%
0.15
41.12%
0.09
39.15%
0.04
56.41%
0.05
15.75%
0.02
53.84%
0.03
43.27%
0.04
40.19%
0.02
52.72%
stock based compensation to revenue
tangible asset value
11.57M
-
32.43M
180.36%
82.78M
155.26%
56.38M
31.88%
32.50M
42.36%
10.41M
67.97%
20.84M
100.18%
18.06M
13.33%
39.68M
119.68%
46.11M
16.20%
24.72M
46.39%
tangible book value per share
0.05
-
0.12
110.03%
0.25
114.09%
0.14
41.85%
0.08
42.72%
0.03
68.15%
0.04
33.68%
0.02
57.10%
0.02
57.31%
0.03
36.59%
0.01
62.13%
working capital
11.40M
-
32.14M
181.85%
82.45M
156.51%
55.79M
32.34%
32.14M
42.39%
10.31M
67.91%
20.34M
97.26%
17.52M
13.89%
39.42M
125.04%
46.09M
16.92%
24.80M
46.19%

All numbers in (except ratios and percentages)